Severe depression following á-interferon usage in a patient with chronic myeloid leukemia

African Health Sciences

Volumn 9, Issue 1, 2009, Pages 54-56

  Mamman, Aisha I ^a   Yusuf, A J ^a   Aminu, Sm ^a   Sheikh, T L ^a   Hassan, A ^a  

^a NONE

Author keywords

Chronic myeloid leukaemia; Depression; Interferon

Indexed keywords

ALPHA INTERFERON; HYDROXYUREA; ANTIVIRUS AGENT;

ADULT; ARTICLE; CASE REPORT; CHRONIC MYELOID LEUKEMIA; DEPRESSION; DISEASE SEVERITY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEVER; FOLLOW UP; HUMAN; LEUKEMIA REMISSION; MALE; MUSCLE WEAKNESS; MYALGIA; NEUROPSYCHOLOGICAL TEST; NIGERIA; SUICIDAL IDEATION; TREATMENT OUTCOME; CHEMICALLY INDUCED; COMPLICATION; LEUKEMIA, MYELOID, CHRONIC-PHASE; PSYCHOLOGY;

ADULT; ANTIVIRAL AGENTS; DEPRESSION; HUMANS; INTERFERON-ALPHA; LEUKEMIA, MYELOID, CHRONIC-PHASE; MALE; TREATMENT OUTCOME;

EID: 77949409356     PISSN: 16806905     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Vardiman JW, Imbert M, Pierre R, Brunning RD, Thiele J, Flandrin G, Chronic myelogenous leukaemia in: World Health Organisation Classification of Tumours. Pathology and Genetics of Tumours of Haempoietic and Lymphoid Tissues by Jaffe ES, Harris NL, Stein H, Vardiman JW (eds): p 20-26. IARC Press Lyon 2001.
2. Stefan Faderl, Moshe Talpaz, Zeev Estrov, Susan O'Brien, Razelle Kurzrock, Hagop M. Kantarjian, M. The Biology of Chronic Myeloid Leukemia, N Engl J Med 1999; 341(3):164-172.
3. Hagop M. Kantarjian, Terry L. Smith, Susan O'Brien, Prolonged Survival in Chronic Myelogenous Leukaemia after Cytogenetic Response to Interferon-a Therapy. Annals of Int Medicine, 1995; 122(4): 254-61.
4. Mahon FX, Fabères C, Pueyo S, Cony-Makhoul P, Salmi R, Boiron JM, Marit G, Bilhou-Nabera C, Carrère A, Montastruc M, Pigneux A, Bernard Ph, and Reiffers J, Response at Three Months Is a Good Predictive Factor for Newly Diagnosed Chronic Myeloid Leukemia Patients Treated by Recombinant Interferon-á . Blood, 1998; 92 (11): pp. 4059-4065.
5. Sante Ture, Gianantonio Rosti, Antonio de Rosti et al, Long Term Follow-Up of the Italian Trial of Interferon á Versus Conventional Chemotherapy in Chronic Myeloid Leukaemia, Blood, 1998; 92(5):1541- 48.
6. Okanny CC, Durosinmi MA Chukwuani CM, et al Interferon alfa (Roferon A® ) monotherapy in chronic myelogenous leukaemia: a pilot study in Nigerian patients in early chronic phase. West African Journal of Medicine 2000; 19(4):286-92
7. Martee L. Hensley, Bercedes Peterson et al, Risk factors for Severe Neuropsychiatric Toxicity in Patients Receiving Interferon-Alpha 2b and Low dose Cytarabine for Chronic Myelogenous Leukaemia: Analysis of Cancer and Leukaemia Group B 9013, J Clin Oncol 2000;18(6): 1301-8.
8. Renault PF., Hoofnagle JH. , et al Psychiatric Complications of Long Term Interferon Alpha therapy, Acta Intern Med 1987; 147: 1577-80.
9. Wandl U.B., Kloke O., Nagel-Hieuke M. et al, Combination therapy with interferon alpha-2b plus low dose interferon gamma in pretreated patients with Philadelphia Chromosome Positive Chronic Myeloid Leukaemia, Br J Haematol 1992; 81(4): 516-9.
10. Tamam L., Yerdelen D., Ozpoyraz N, Psychosis associated with Interferon Alfa Therapy for Chronic Hepatitis B, Annals of Pharmacotherapy 2003;37(3): 384-7.
11. Asnis G.M., De La Garza II Kohn, S.R., Interferon Induced Depression: A role for NSAIDs Psychopharmacol Bull, 2003; 37(3): 29-50
12. Preble, O.T., Torrey, E.F., Serum interferon in patients with psychosis, Am J Psychiatry 1985; 142(10): 1184-6.
13. G.T.A. Jombo, M.N.O. Enenebeaku, S.J. Utsalo: Clinical Diagnosis of Enteric Fever and the Potential Benefits in the Management of Enteric Fevers in the Developing World. The Internet Journal of Parasitic Diseases. 2007; 2(2).
14. th August 2007.
15. Laura McIlwaine, Lubomir Sokol, Lynn C Muscanir, Hussein I Saba. Acute Myeloblastic Leukaemia mimicking primary testicular neoplasm: Presentation of a case and a review of literature. Eur J Haematol 2003; 70(4):242-6
16. Boma PO, Durosinmi MA, Adediran IA, Akinola NO, Salawu L. Clinical and Prognostic Features of Nigerians with Chronic Myeloid Leukaemia. Nigerian Postgraduate Medical Journal 2006; 13(1):47-52